SNORD19B: SNORD19B is a small nucleolar RNA (snoRNA) that has been associated with major psychiatric mood disorders and lipid and glucose abnormalities in patients using atypical or second-generation antipsychotics [PMC4382905] [Pramyothin and Khaodhiar, 2010]. In hepatocellular carcinoma (HCC), high expression levels of SNORD19B were shown to be prognostic of shorter time to relapse [PMC8677010]. SNORD19B is one of the genes that regulate the process of mobility [PMC4637305]. In a study on bladder cancer (BLCA), SNORD19B was found to be a beneficial factor for patients, as indicated by KM survival curves [PMC7350589]. SNORD19B, along with other snoRNAs, was identified as an independent prognostic factor in cancer and was used to construct a prognostic risk score model [PMC9454744]. The expression of SNORD19B was negatively correlated with ACVRL1 in bladder cancer patients [PMC7350589]. Additionally, the expression of SNORD19B was positively correlated with its copy number variation (CNV) in bladder cancer patients [PMC7350589]. Furthermore, SNORD19B had a correlation with CD20 in bladder cancer patients [PMC7350589].